Key Takeaways
- Axitan has appointed Guillermo Zavala as Vice President of Sales and Marketing.
- Zavala will lead the expansion of Axitan’s commercial activities in North America and international markets.
- The appointment comes as Axitan’s first endolysin-based products gain traction across multiple regions.
- The company continues to expand its endolysin technology and gel-based Hatch.life delivery platform.
- Zavala brings extensive experience in animal nutrition, veterinary science, and global sales leadership.
Axitan Announces Commercial Leadership Appointment
Axitan Inc., a biotechnology company developing endolysin-based products as alternatives to antibiotics in the animal protein industry, announced the appointment of Guillermo Zavala as Vice President of Sales and Marketing. In this role, Zavala will be responsible for supporting Axitan’s commercial growth and expanding the company’s presence in North American and international markets.
The company stated that the appointment aligns with increased market momentum for its initial product portfolio and continued development of its technology platforms.
Supporting Growth of Axitan's Endolysin-Based Solutions
Axitan’s product portfolio is built around endolysins, antimicrobial enzymes that target pathogenic bacteria. These enzymes form the foundation of the company’s antibiotic-free solutions designed to address productivity and bacterial challenges across multiple animal species. The company's products can be delivered through various formats, including dry feed, gel, water, and solid dose applications.
